-

BioFuture 2025 Returns to New York City October 13-15

New Therapeutic Spotlight Series Fosters Meaningful Dialogue Between Innovators, Industry Leaders, Investors, and Potential Partners

NEW YORK--(BUSINESS WIRE)--In person and virtual registration is now open for Demy-Colton’s BioFuture™ conference, providing leading investors, innovators, industry media, regulators, policymakers and biopharmaceutical companies the strategic insights and powerful relationships needed to lead in the biopharma and healthcare ecosystem.

BioFuture is where today’s brightest minds come together to chart the course of tomorrow’s healthcare.

Share

The conference will take place at Cure in New York City, October 13-15, 2025, and a virtual partnering option is offered October 21-23 including access to the event’s recorded content.

“BioFuture is where today’s brightest minds come together to chart the course of tomorrow’s healthcare,” said Sara Demy, CEO and Founder of Demy-Colton. “We are bringing together the people leading that charge, and this year we’re especially excited to introduce Therapeutic Spotlight Panels, a new way to showcase innovative companies. This new series will shine a light on companies and innovators shaping the future of healthcare in key therapeutic areas such as neuroscience, aging, diagnostics, obesity, cancer and more.”

As noted above, this year’s conference will introduce the Therapeutic Spotlight Series, where innovative biopharma companies will participate in hour-long, focused panel discussions about therapeutic innovations and cutting-edge technologies or advancements that will profoundly change healthcare. Innovative public, private and seed companies are encouraged to submit an application to present at BioFuture as part of a Therapeutic Spotlight Panel or the Seed Showcase. We are seeking biopharma companies developing new therapeutics as well as companies engaged in facilitating the discovery of new therapeutic technologies across biotech, techbio, digital medicine, healthtech, AI, machine learning, big data and healthcare delivery.

Spotlight Panels for Public & Private companies, and presentation slots for Seed companies are available in all therapeutic categories including:

  • Small/large molecule R&D therapeutic
  • Platform
  • Tool
  • Delivery
  • Molecular diagnostic and personalized medicine
  • Research focused service providers
  • Digital Medicine
  • Artificial Intelligence (AI) and Machine Learning (ML)
  • Medical Devices
  • TechBio

For information on presentation or sponsorship opportunities, please contact Lila Taylor at ltaylor@demy-colton.com. For more information about BioFuture or to register, please visit www.biofuture.com and follow #BioFuture2025 on LinkedIn and X for the latest updates and discussions.

About Demy-Colton

Demy-Colton is a leading life sciences and digital health events organization at the forefront of building networks between innovative life sciences companies and industry stakeholders. Its unique events facilitate networking on a global scale, including Biotech Showcase™, BioFuture™, Global Biotech CEO Summit™, Executive Clinics™, and Demy-Colton Virtual Salons™. These events build networking communities that transcend geographical boundaries and establish ongoing, high-value relationships among the industry’s top decision-makers, investors and thought leaders. For more information, visit www.demy-colton.com.

Contacts

Media Contact:
Katie Morris
katiemorris@ententeinc.com

Sponsorship & Presenting Company Contact:
Lila Taylor
ltaylor@demy-colton.com

BioFuture


Release Summary
BioFuture 2025 Returns to New York City October 13-15
Release Versions

Contacts

Media Contact:
Katie Morris
katiemorris@ententeinc.com

Sponsorship & Presenting Company Contact:
Lila Taylor
ltaylor@demy-colton.com

Social Media Profiles
More News From BioFuture

Biotech Showcase™ 2025: Innovation Insights for the Year Ahead

SAN FRANCISCO--(BUSINESS WIRE)--Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media...

Biotech Showcase™ Sets the Stage for Industry Transformation in 2025

SAN FRANCISCO--(BUSINESS WIRE)--Biotech Showcase™ Sets the Stage for Industry Transformation in 2025...

Biotech Showcase™ 2025: 3,200+ Attendees and 1,200+ Investors Set to Convene in San Francisco for Leading Biotech Investor Conference

SAN FRANCISCO--(BUSINESS WIRE)--Marking its 17th year, Biotech Showcase™ will once again serve as the premier destination for global biopharma leaders to connect and advance innovation during J.P. Morgan Healthcare Week. Taking place January 13-15, 2025, in San Francisco, and virtually from January 21-22, 2025, the event will bring together more than 3,200 professionals, including over 1,200 investors, from across the life sciences industry. As the largest and most influential investor conferen...
Back to Newsroom